Medication info
Medirol M Tablets 2/500 Milligrams (Glimepiride, Metformin Hydrochloride)

Medirol M Tablets 2/500 Milligrams (Glimepiride, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201107199 · Notified 2011.09.27 · Insurance code 644003180

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to the results of blood glucose monitoring, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next dosing time.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes to control their blood sugar more effectively. Glimepiride and metformin work together to assist with meal and exercise therapy, improving blood sugar levels. This facilitates better blood sugar management for patients, supporting a healthier lifestyle. Therefore, it is used for blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

This medicine is administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to the results of blood glucose monitoring, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next dosing time.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so caution is needed. Particularly, if kidney function declines rapidly, metformin may accumulate in the body, increasing the risk of lactic acidosis. It is advisable to temporarily suspend medication and consult with a doctor if symptoms of dehydration occur. Care should also be taken when administered with other medications that can affect kidney function. Excessive alcohol intake, liver dysfunction, poorly controlled diabetes, prolonged fasting, and other factors can also pose risks. This medication should not be administered to patients with insulin-dependent diabetes or acute metabolic acidosis. Pregnant or breastfeeding women should also avoid use, and it is not administered to those with severe liver or kidney dysfunction. During the initial use of the medication, there is a high risk of hypoglycemia, so meals should be scheduled regularly and monitored carefully. Gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may occur, and these symptoms are usually temporary. If allergic reactions occur, the physician should be notified immediately, and rare blood disorders or vitamin B12 deficiency can also occur, necessitating regular check-ups. Blood sugar control status should be regularly monitored, and excessive alcohol consumption should be avoided during medication use. Furthermore, there may be interactions with other medications, so all medications currently being taken should be disclosed to healthcare professionals. In case of overdose, hypoglycemia or lactic acidosis may occur, requiring immediate medical assistance. The elderly may need dosage adjustments and regular renal function tests due to decreased kidney function. This medication has not established safety and efficacy for children, so caution is recommended, and one should be careful when driving or operating machinery due to potential hypoglycemia or impaired agility.

Side effects

Hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, dyspepsia, constipation, abdominal pain, nausea, vomiting, feeling of fullness or pressure in the upper abdomen, metallic taste, visual impairment, taste disorders, erythema, itching, hives, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, decreased vitamin B12, peripheral neuropathy, increased liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity of the skin, decreased serum sodium concentration, decreased thyrotropin level, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, symptoms of hypoglycemia (headache, severe hunger, nausea, vomiting, fatigue, sleepiness, weakness, drowsiness, sleep disorders, instability, aggression, attention deficit, inability to concentrate, abnormal responses, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak breathing, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.